AspenBio Pharma, Inc. Stock Nasdaq
Equities
US0453462022
Blockchain & Cryptocurrency
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 22 | Top Cryptocurrencies Rise; Bitcoin Zooms Past $66,000 | MT |
Apr. 19 | Top Cryptocurrencies Rise; Bitcoin Hovers Above $64,000 | MT |
Financials (USD)
Sales 2024 * | 492M | Sales 2025 * | 859M | Capitalization | 2.85B |
---|---|---|---|---|---|
Net income 2024 * | -126M | Net income 2025 * | 222M | EV / Sales 2024 * | 3.04 x |
Net cash position 2024 * | 1.35B | Net cash position 2025 * | 1.9B | EV / Sales 2025 * | 1.11 x |
P/E ratio 2024 * |
-21.2
x | P/E ratio 2025 * |
17.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.76% |
Managers | Title | Age | Since |
---|---|---|---|
Jason Les
CEO | Chief Executive Officer | 38 | 17-11-02 |
Colin Yee
DFI | Director of Finance/CFO | 48 | 22-03-31 |
David Schatz
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Hubert Marleau
BRD | Director/Board Member | 80 | 20-11-16 |
Lance D'Ambrosio
BRD | Director/Board Member | 66 | 21-05-23 |
Benjamin Yi
CHM | Chairman | 42 | 18-10-21 |
1st Jan change | Capi. | |
---|---|---|
-25.29% | 4.7B | |
+73.07% | 4.3B | |
+10.41% | 1.33B | |
-30.88% | 823M | |
-32.56% | 769M | |
+7.50% | 780M | |
-26.75% | 732M | |
-73.69% | 468M | |
-59.79% | 333M |